AU Patent

AU2016204422B2 — Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Assigned to Vertex Pharmaceuticals Inc · Expires 2017-11-16 · 9y expired

What this patent protects

[00228] The present invention relates to a process of providing the 3-(6-(1-(2,2 difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in substantially free form (Compound 1). - 61 -

USPTO Abstract

[00228] The present invention relates to a process of providing the 3-(6-(1-(2,2 difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in substantially free form (Compound 1). - 61 -

Drugs covered by this patent

Patent Metadata

Patent number
AU2016204422B2
Jurisdiction
AU
Classification
—
Expires
2017-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.